Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

FSD Acquires Nasdaq CBD Pharma Company

Stockhouse Editorial
2 Comments| October 23, 2018

FSD Pharma Inc. (CSE: HUGEOTCQB: FSDDFForum) on Tuesday announced that it has signed a binding letter of intent to acquire Therapix Biosciences Ltd. (NASDAQ: TRPX), thus combining two businesses to advance research and development of advanced cannabinoid treatments. Therapix shareholders will receive $62.4 million (CAD) of FSD stock upon closing of the transaction, which represents around 130 million class B subordinate shares of FSD Pharma and nearly 10% of the Company today.

For more information on this, click here.

FSD was in the news recently when it began construction of its heritage museum and flagship dispensary at the former Kraft plant in Cobourg, Ontario.

FULL DISCLOSURE: FSD Pharma Inc. is a paid client of Stockhouse Publishing.

Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Metals & Mining

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.


October 24, 2018

The company THERAPIX trades at < $5. Seems too good to be true why the downturn today. Should rally back I bought more today long hold for HUGE
October 23, 2018

Leave a Comment

You must be logged in to access this feature.


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.